Flutikrit F 250 Capsule is a combination medication containing Formoterol (6mcg) and Fluticasone Propionate (250mcg), primarily used for the management and prevention of asthma and chronic obstructive pulmonary disease (COPD). Formoterol is a long-acting beta2-adrenergic agonist (LABA) that works by relaxing the muscles in the airways, leading to bronchodilation and improved airflow. Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, helping to prevent asthma attacks and exacerbations of COPD. Together, these active ingredients provide both immediate and sustained relief from bronchospasm while controlling underlying inflammation, making Flutikrit F 250 effective for long-term respiratory management. This capsule is typically prescribed for patients who require regular maintenance therapy to control persistent symptoms and improve lung function. It is important to use Flutikrit F 250 consistently as directed by a healthcare professional and not to use it for acute asthma attacks. Common side effects may include throat irritation, hoarseness, and oral candidiasis, which can be minimized by rinsing the mouth after use. Patients should consult their doctor before starting this medication, especially if they have other medical conditions or are taking additional drugs.